Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trialTakayuki Sumiyoshi, Himisha Beltran, Sheng‐Yu Ku et al.|JNCI Journal of the National Cancer Institute|2023Cited by 9